What's stopping myeloma patients from getting CAR T-Cell therapy?
NCT ID NCT06126341
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study observes 49 patients with relapsed or refractory multiple myeloma and their doctors to find out why some patients don't receive advanced cell therapies like CAR T-cells or stem cell transplants. Researchers will track referral rates and use questionnaires to measure anxiety, depression, and social support. The goal is to identify barriers and improve access to these treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors understand and remove barriers so more patients can access advanced cell therapies for multiple myeloma.
- What could go wrong
- This is an observational study with only 49 participants, so findings may not apply to everyone. It does not test a new treatment itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hartford Healthcare Alliance
Hartford, Connecticut, 06102, United States
-
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Bergen
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Commack
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau
Uniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact